BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32702842)

  • 1. Treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
    Liao W; Liu Y
    Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.
    Ragab AH; Abdel-Mageed A; Shuster JJ; Frankel LS; Pullen J; van Eys J; Sullivan MP; Boyett J; Borowitz M; Crist WM
    Cancer; 1991 Feb; 67(4):1057-63. PubMed ID: 1825025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
    Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
    Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
    Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
    Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
    Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
    Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
    Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
    Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
    Rajantie J; Siimes MA
    J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
    Wheeler K; Chessells JM; Bailey CC; Richards SM
    Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.
    Kalwinsky DK; Raimondi SC; Bunin NJ; Fairclough D; Pui CH; Relling MV; Ribeiro R; Rivera GK
    Am J Med Genet Suppl; 1990; 7():267-71. PubMed ID: 2149960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
    Patrick K; Wade R; Goulden N; Rowntree C; Hough R; Moorman AV; Mitchell CD; Vora A
    Br J Haematol; 2014 May; 165(4):552-5. PubMed ID: 24428704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
    Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT; Kennedy-Nasser AA; Kitko C; Kurtzberg J; Lehmann L; O'Brien T; Pulsipher MA; Smith FO; Zhang MJ; Eapen M; Carpenter PA;
    Pediatr Blood Cancer; 2014 Jun; 61(6):1126-8. PubMed ID: 24391118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
    Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
    Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.
    Rabin KR; Smith J; Kozinetz CA
    Pediatr Blood Cancer; 2012 Apr; 58(4):633-5. PubMed ID: 22106003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Levinsen M; Rosthøj S; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Schmiegelow K;
    Leukemia; 2013 Apr; 27(4):866-70. PubMed ID: 23138181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat ALL in Down's syndrome: pathobiology and management.
    Izraeli S; Vora A; Zwaan CM; Whitlock J
    Blood; 2014 Jan; 123(1):35-40. PubMed ID: 24235135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer Group.
    Finklestein JZ; Miller DR; Feusner J; Stram DO; Baum E; Shina DC; Johnson DG; Gyepes MT; Hammond GD
    Cancer; 1994 Jan; 73(1):219-23. PubMed ID: 8275428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.